These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 18046914)

  • 21. Strontium ranelate reduces the risk of vertebral fracture in young postmenopausal women with severe osteoporosis.
    Roux C; Fechtenbaum J; Kolta S; Isaia G; Andia JB; Devogelaer JP
    Ann Rheum Dis; 2008 Dec; 67(12):1736-8. PubMed ID: 18713788
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Strontium ranelate reduces the risk of vertebral fractures in patients with osteopenia.
    Seeman E; Devogelaer JP; Lorenc R; Spector T; Brixen K; Balogh A; Stucki G; Reginster JY
    J Bone Miner Res; 2008 Mar; 23(3):433-8. PubMed ID: 17997711
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vertebral fracture risk reduction with strontium ranelate in women with postmenopausal osteoporosis is independent of baseline risk factors.
    Roux C; Reginster JY; Fechtenbaum J; Kolta S; Sawicki A; Tulassay Z; Luisetto G; Padrino JM; Doyle D; Prince R; Fardellone P; Sorensen OH; Meunier PJ
    J Bone Miner Res; 2006 Apr; 21(4):536-42. PubMed ID: 16598373
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of strontium ranelate in the treatment of osteoporosis in men.
    Kaufman JM; Audran M; Bianchi G; Braga V; Diaz-Curiel M; Francis RM; Goemaere S; Josse R; Palacios S; Ringe JD; Felsenberg D; Boonen S
    J Clin Endocrinol Metab; 2013 Feb; 98(2):592-601. PubMed ID: 23341486
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Strontium ranelate in the prevention of osteoporotic fractures.
    Reginster JY; Malaise O; Neuprez A; Bruyere O
    Int J Clin Pract; 2007 Feb; 61(2):324-8. PubMed ID: 17263720
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A new treatment for post-menopausal osteoporosis: strontium ranelate.
    Rizzoli R
    J Endocrinol Invest; 2005; 28(8 Suppl):50-7. PubMed ID: 16323829
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A review of strontium ranelate and its effect on DXA scans.
    Blake GM; Lewiecki EM; Kendler DL; Fogelman I
    J Clin Densitom; 2007; 10(2):113-9. PubMed ID: 17485027
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Osteoporosis: from early fracture prevention to better bone health with strontium ranelate.
    Cortet B
    Rheumatology (Oxford); 2009 Oct; 48 Suppl 4():iv14-9. PubMed ID: 19783589
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prospective assessment of thoracic kyphosis in postmenopausal women with osteoporosis.
    Roux C; Fechtenbaum J; Kolta S; Said-Nahal R; Briot K; Benhamou CL
    J Bone Miner Res; 2010 Feb; 25(2):362-8. PubMed ID: 19594302
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between change in femoral neck bone mineral density and hip fracture incidence during treatment with strontium ranelate.
    Bruyère O; Roux C; Badurski J; Isaia G; de Vernejoul MC; Cannata J; Ortolani S; Slosman D; Detilleux J; Reginster JY
    Curr Med Res Opin; 2007 Dec; 23(12):3041-5. PubMed ID: 17967221
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comprehensive therapy in osteoporosis using a single drug: from ADFR to strontium ranelate.
    Manette C; Collette J; Sarlet N; Tancredi A; Zegels B; Reginster JY
    Curr Med Chem; 2006; 13(13):1585-90. PubMed ID: 16787205
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Strontium ranelate: a review of its use in the treatment of postmenopausal osteoporosis.
    Deeks ED; Dhillon S
    Drugs; 2010 Apr; 70(6):733-59. PubMed ID: 20394457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Strontium ranelate for the management of osteoporosis.
    Lam S; Zouzias K
    Consult Pharm; 2008 Jul; 23(7):531-7. PubMed ID: 18764671
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Strontium ranelate: a new paradigm in the treatment of osteoporosis.
    Reginster JY; Lecart MP; Deroisy R; Lousberg C
    Expert Opin Investig Drugs; 2004 Jul; 13(7):857-64. PubMed ID: 15212623
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hip cortical thickness assessment in postmenopausal women with osteoporosis and strontium ranelate effect on hip geometry.
    Briot K; Benhamou CL; Roux C
    J Clin Densitom; 2012; 15(2):176-85. PubMed ID: 22321661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between bone mineral density changes and fracture risk reduction in patients treated with strontium ranelate.
    Bruyere O; Roux C; Detilleux J; Slosman DO; Spector TD; Fardellone P; Brixen K; Devogelaer JP; Diaz-Curiel M; Albanese C; Kaufman JM; Pors-Nielsen S; Reginster JY
    J Clin Endocrinol Metab; 2007 Aug; 92(8):3076-81. PubMed ID: 17566094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Continuous broad protection against osteoporotic fractures with strontium ranelate.
    Ferrari S
    Rheumatology (Oxford); 2009 Oct; 48 Suppl 4():iv20-4. PubMed ID: 19783590
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vertebral anti-fracture efficacy of strontium ranelate according to pre-treatment bone turnover.
    Collette J; Bruyère O; Kaufman JM; Lorenc R; Felsenberg D; Spector TD; Diaz-Curiel M; Boonen S; Reginster JY
    Osteoporos Int; 2010 Feb; 21(2):233-41. PubMed ID: 19436941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Strontium ranelate: a new therapeutic principle for postmenopausal osteoporosis].
    Mosekilde L; Nielsen LR; Vestergaard P
    Ugeskr Laeger; 2005 Sep; 167(37):3485-7. PubMed ID: 16159455
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Strontium ranelate prevents quality of life impairment in post-menopausal women with established vertebral osteoporosis.
    Marquis P; Roux C; de la Loge C; Diaz-Curiel M; Cormier C; Isaia G; Badurski J; Wark J; Meunier PJ
    Osteoporos Int; 2008 Apr; 19(4):503-10. PubMed ID: 17929073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.